Small molecules, big targets: drug discovery faces the protein–protein interaction challenge

Cited by (1,001)

Items 701–800 of 1,001

1. Synthesis, biological evaluation, molecular docking, and ADMET studies of some isoxazole-based amides
   Sushama S. Kauthale, Sunil U. Tekale, Manoj G. Damale, Jaiprakash Navnath Sangshetti, Rajendra P. Pawar · 2017 · Medicinal Chemistry Research
2. Hot-spot guided design of macrocyclic inhibitors of the LSD1-CoREST1 interaction
   Peter ‘t Hart, Joseph Openy, Adrian Krzyzanowski, Hélène Adihou, Herbert Waldmann · 2019 · Tetrahedron
3. Evaluation of the RAS signaling network in response to MEK inhibition using organoids derived from a familial adenomatous polyposis patient
   Hiroki Osumi, Atsushi Muroi, Mizuho Sakahara, Hiroshi Kawachi, Takuya Okamoto, Yasuko Natsume, Hitomi Yamanaka, Hiroshi Takano, Daisuke Kusama, Eiji Shinozaki et al. · 2020 · Scientific Reports
4. A Modular Synthesis of Teraryl‐Based α‐Helix Mimetics, Part 3: Iodophenyltriflate Core Fragments Featuring Side Chains of Proteinogenic Amino Acids
   Melanie Trobe, Martin Vareka, Till Schreiner, Patrick Simon Dobrounig, Carina Doler, Ella B. Holzinger, Andreas Steinegger, Rolf Breinbauer · 2022 · European Journal of Organic Chemistry
5. Potentiating Tweezer Affinity to a Protein Interface with Sequence-Defined Macromolecules on Nanoparticles
   Theresa Seiler, Annika Lennartz, Kai Klein, Katrin Hommel, Antonio Figueroa Bietti, Inesa Hadrović, Sebastian Kollenda, Jonas Sager, Christine Beuck, Emilia Chlosta et al. · 2023 · Biomacromolecules
6. Exploring Non‐obvious Hydrophobic Binding Pockets on Protein Surfaces: Increasing Affinities in Peptide–Protein Interactions
   Aleksandra Balliu, Lars Baltzer · 2017 · ChemBioChem
7. Structure-based discovery of novel small molecule inhibitors of platelet-derived growth factor-B
   Omid Zarei, Niki Sarri, Siavoush Dastmalchi, Fateme Zokai, Natalia Papadopoulos, Johan Lennartsson, Carl‐Henrik Heldin, Maryam Hamzeh‐Mivehroud · 2019 · Bioorganic Chemistry
8. Docking, Scoring, and Virtual Screening in Drug Discovery
   Francesca Spyrakis, Aurijit Sarkar, Glen E. Kellogg · 2021 · Burger's Medicinal Chemistry and Drug Discovery
9. Tracking chromatin state changes using μ Map photo-proximity labeling
   Ciaran P. Seath, Antony J. Burton, David W. C. MacMillan, Tom W. Muir · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
10. Förster Resonance Energy Transfer Measurements in Living Bacteria for Interaction Studies of BamA with BamD and Inhibitor Identification
    Sebastian Schreiber, Joachim Jose · 2024 · Cells
11. Triazine Macrocycle Libraries: Synthesis, logD Prediction, and a Surprisingly Hydrophobic, Membrane-Permeable Diamine
    Gretel A. Stokes, Casey J. Patterson-Gardner, Alexander M. Engstrom, Alexander J. Menke, K. Harsha Vardhan Reddy, R. Scott Lokey, Eric E. Simanek · 2025 · ACS Medicinal Chemistry Letters
12. Computational and experimental discovery of peptide inhibitors targeting survivin for therapeutic potential in cancer
    Seyedeh Fatemeh Ahmadi, Seyed Shahriar Arab, Hamid Reza Samadikhah · 2025 · Scientific Reports
13. Automated and modular protein binder design with BinderFlow
    Nayim González-Rodríguez, Nayim González-Rodríguez, Óscar Llorca, Rafael Fernández-Leiro · 2025 · PLoS Computational Biology
14. Discovery of thiadiazole-based small-molecule inhibitors of SARS-CoV-2 spike-ACE2 interaction through integrated computational prediction and experimental validation
    Zakkia Gul, Syed Ahsan Shahid, Obaid‐ur‐Rahman Abid, Muhammad Waqas, Shazia Rafique, Ahmed E. Al-Sabri, Asma Sardar, Afrah Fahad ALKHURIJI, Nawal M. Al-Malahi, Muhammad Irfan et al. · 2026 · Scientific Reports
15. Small-Molecule Inhibition of SOST Suppresses Breast Cancer Bone Metastasis
    Yousef Hamdan Khalil, Omar Salman Nassar · 2025 · Archive of International Journal of Cancer and Allied Science
16. Synthesis of 14-membered enediyne-embedded macrocycles
    Mladena Glavaš, Matija Gredičak, Zoran Štefanić, Ivanka Jerić · 2022 · Organic & Biomolecular Chemistry
17. Multivalent Molecular Tweezers Disrupt the Essential NDC80 Interaction with Microtubules
    Jonas Neblik, Abbna Kirupakaran, Christine Beuck, Joel Mieres‐Pérez, Felix C. Niemeyer, My‐Hue Le, Ursula Telgheder, Jessica Felice Schmuck, Alexander Dudziak, Peter Bayer et al. · 2023 · Journal of the American Chemical Society
18. OTTM: an automated classification tool for translational drug discovery from omics data
    Xiaobo Yang, Bei Zhang, Siqi Wang, Ye Lu, Kaixian Chen, Cheng Luo, Aihua Sun, Hao Zhang · 2023 · Briefings in Bioinformatics
19. Validation of aminodeoxychorismate synthase and anthranilate synthase as novel targets for bispecific antibiotics inhibiting conserved protein-protein interactions
    Franziska Jasmin Funke, Sandra Schlee, Reinhard Sterner · 2024 · Applied and Environmental Microbiology
20. Deciphering the potential role of post-translational modifications of histones in gastrointestinal cancers: a proteomics-based review with therapeutic challenges and opportunities
    Reyhaneh Farrokhi Yekta, Masoumeh Farahani, Mehdi Koushki, Nasrin Amiri Dashatan · 2024 · Frontiers in Oncology
21. Enhancing Cytoplasmic Expression of Exogenous mRNA Through Dynamic Mechanical Stimulation
    Jiawen Chen, Aneri Patel, Mohammad Mir, Maria R. Hudock, Meghan R. Pinezich, Brandon A. Guenthart, Matthew D. Bacchetta, Gordana Vunjak‐Novakovic, Jin-Ho Kim · 2024 · Advanced Healthcare Materials
22. Structural Modifications for Biological Activity Enhancements in Thiosemicarbazone Scaffolds and Their Metal Complexes
    Tahmeena Khan, Saman Raza, Kulsum Hashmi, Mohammad Imran Ahmad, Abdul Rahman Khan · 2025 · Synlett
23. Expression patterns, structural features, and roles of SRPX2 in disease pathogenesis
    Jiali Wang, Manling Lang, Qifei Cong · 2025 · Glycoscience & Therapy
24. Effects of serum matrix on molecular interactions between drugs and target proteins revealed by giant magneto-resistive bio-sensing techniques
    Toshiro Saito, Masayoshi Momiyama, Chihiro Manri, Heng Yu, Kalidip Choudhury, Sebastian J. Osterfeld, Takashi Nakasawa · 2021 · Journal of Pharmaceutical and Biomedical Analysis
25. Development of Peptide-Based PDZ Domain Inhibitors
    Dominik J. Essig, Javier Rodríguez, Kristian Strømgaard · 2021 · Methods in molecular biology
26. Towards optimizing peptide-based inhibitors of protein–protein interactions: predictive saturation variation scanning (PreSaVS)
    Kristina Hetherington, Som Dutt, Amaurys Ávila Ibarra, Emma E. Cawood, Fruzsina Hóbor, Derek N. Woolfson, Thomas A. Edwards, Adam S. Nelson, Richard Barry Sessions, Andrew John Wilson · 2021 · RSC Chemical Biology
27. Systematic analysis of the potential off-target activities of osimertinib by computational target fishing
    Shao-jun Chen, Yan-hua Bi, Li-hua Zhang · 2021 · Anti-Cancer Drugs
28. Improved prediction of protein-protein interactions by a modified strategy using three conventional docking software in combination
    Sungwoo Choi, Seung Han Son, Min Young Kim, Insung Na, Vladimir Nikolaevich Uversky, Chul Geun Kim · 2023 · International Journal of Biological Macromolecules
29. Modulation of HIV-1 capsid multimerization by sennoside A and sennoside B via interaction with the NTD/CTD interface in capsid hexamer
    Dawei Zhang, Xiaoshuang Xu, Rui Zhou, Zhiguo Fu · 2023 · Frontiers in Microbiology
30. Profiling Protein–Protein Interactions in the Human Brain by Refined Cofractionation Mass Spectrometry
    Him K. Shrestha, Dong Geun Lee, Zhiping Wu, Zhen Wang, Yingxue Fu, Xusheng Wang, Geidy E. Serrano, Thomas G. Beach, Junmin Peng · 2024 · Journal of Proteome Research
31. Structure-Based Design and Discovery of a Potent and Cell-Active LC3A/B Covalent Inhibitor
    Zhenfei Zhou, Siqi Huang, Shijie Fan, Xueyuan Li, Chengyu Wang, W. Yu, Daohai Du, Yuanyuan Zhang, Kaixian Chen, Wei Fu et al. · 2024 · Journal of Medicinal Chemistry
32. Identification of novel RANKL inhibitors through in silico analysis
    Yingying Jiang, Xiaogang Luo, Zhanpeng Zheng, Shun Wen, Hongwei Gao, Cheng Xu, Min Jiang, Siyuan Wang · 2024 · Bioorganic Chemistry
33. Modular Nanotransporters Deliver Anti-Keap1 Monobody into Mouse Hepatocytes, Thereby Inhibiting Production of Reactive Oxygen Species
    Yuri V. Khramtsov, Alexey V. Ulasov, Andrey A. Rosenkranz, Tatiana A. Slastnikova, Tatiana N. Lupanova, Georgii Pavlovich Georgiev, Alexander S. Sobolev · 2024 · Pharmaceutics
34. NABi, a novel β-sheet breaker, inhibits Aβ aggregation and neuronal toxicity: Therapeutic implications for Alzheimer's disease
    Ja-Young Jang, Hyangshuk Rhim, Seongman Kang · 2017 · Biochimica et Biophysica Acta (BBA) - General Subjects
35. Facile analysis of protein-protein interactions in living cells by enriched visualization of the p-body
    Miri Choi, Jiyeon Baek, Sang‐Bae Han, Sungchan Cho · 2018 · BMB Reports
36. Chemical Space Overlap with Critical Protein–Protein Interface Residues in Commercial and Specialized Small‐Molecule Libraries
    Yubing Si, David Daqiang Xu, Khuchtumur Bum‐Erdene, Mona K. Ghozayel, Baocheng Yang, Paul A. Clemons, Samy O. Meroueh · 2018 · ChemMedChem
37. A proximity-exponential hybridization chain reaction (PEHCR) and its application for nondestructive analysis of membrane protein-protein interactions on living cells
    Dongsheng Mao, Tianshu Chen, Xiaohao Liu, Lingjie Ren, Chang Feng, Guifang Chen · 2020 · Analytica Chimica Acta
38. Fully Automated Protein Proximity Assay in Formalin-Fixed, Paraffin-Embedded Tissue Using Caged Haptens
    Nathan W. Polaske, Brian Kelly, Matthew A. Smith, Eric B. Haura, Yuri Y. Belosludtsev · 2020 · Bioconjugate Chemistry
39. Developing a machine learning model to identify protein–protein interaction hotspots to facilitate drug discovery
    Rohit Nandakumar, Valentin Dinu · 2020 · PeerJ
40. A Multipronged Screening Approach Targeting Inhibition of ETV6 PNT Domain Polymerization
    Chloe A. N. Gerak, Si Miao Zhang, Aruna D. Balgi, Ivan Sadowski, Richard Barry Sessions, Lawrence P. McIntosh, Michel Roberge · 2020 · SLAS DISCOVERY
41. Mass spectrometry-based protein-protein interaction techniques and their applications in studies of DNA damage repair
    Zhen Chen, Junjie Chen · 2021 · Journal of Zhejiang University SCIENCE B
42. Reciprocal Regulation of Hippo and WBP2 Signalling—Implications in Cancer Therapy
    Yvonne Xinyi Lim, Yvonne Xinyi Lim, Sock Hong Seah, Yoon Pin Lim · 2021 · Cells
43. A Modular Synthesis of Teraryl‐Based α‐Helix Mimetics, Part 4: Core Fragments with Two Halide Leaving Groups Featuring Side Chains of Proteinogenic Amino Acids
    Melanie Trobe, Julia Blesl, Martin Vareka, Till Schreiner, Rolf Breinbauer · 2022 · European Journal of Organic Chemistry
44. Rationally Designed Semisynthetic Natural Product Analogues for Stabilization of 14‐3‐3 Protein–Protein Interactions
    Sebastian A. Andrei, Pim J. de Vink, Eline Sijbesma, Ling Han, Luc Brunsveld, Nobuo Kato, Christian Ottmann, Yusuke Higuchi · 2018 · Angewandte Chemie
45. Bicyclic β‐Sheet Mimetics that Target the Transcriptional Coactivator β‐Catenin and Inhibit Wnt Signaling
    Mathias Wendt, Rosa Bellavita, Alan Gerber, Nina‐Louisa Efrém, Thirza van Ramshorst, Nicholas M. Pearce, Paul R. J. Davey, Isabel Everard, Mercedes Vázquez–Chantada, Elisabetta Chiarparin et al. · 2021 · Angewandte Chemie
46. Can molecular dynamics facilitate the design of protein–protein-interaction inhibitors?
    Masashi Honma, Hiroshi Suzuki · 2022 · Nature Reviews Rheumatology
47. Computational Gene Expression and Network Analysis of Myc Reveal Insights into Its Diagnostic and Prognostic Role in Subtypes of Renal Cancer
    Jyotsna Priyam, Urmila Saxena · 2023 · Applied Biochemistry and Biotechnology
48. Protein – Protein Etkileşimi Tespit Yöntemleri, Veri Tabanları ve Veri Güvenilirliği
    Volkan Altuntaş, Murat Gök · 2020 · European Journal of Science and Technology
49. Structural and evolutionary exploration of the IL-3 family and its alpha subunit receptors
    Jade Fogha, Jagadeesh Bayry, Julien Diharce, Alexandre G. de Brevern · 2021 · Amino Acids
50. Targeting the Architecture of Deregulated Protein Complexes in Cancer
    Eduard Stefan, Jakob Troppmair, Klaus Bister · 2017 · Advances in protein chemistry and structural biology
51. Deep learning in bioinformatics: introduction, application, and perspective in big data era
    Yu Li, Chao Huang, Lizhong Ding, Zhongxiao Li, Yijie Pan, Xin Gao · 2019 · arXiv (Cornell University)
52. Computational Design of Stapled Peptide Inhibitor against SARS-CoV-2 Receptor Binding Domain
    Asha Rani Choudhury, Atanu Maity, Sayantani Chakraborty, Rajarshi Chakrabarti · 2021 · ChemRxiv
53. Stretching Peptides’ Potential to Target Protein–Protein Interactions
    Venneti N. Murty, Jennifer L. Stockdill · 2023 · ACS Central Science
54. Programming Biomolecular Interactions with All-Atom Generative Model
    Xiangzhe Kong, Junwei Chen, Ziting Zhang, Gaodeng Li, Qingyuan Zhu, L Wei, Mingyu Li, Yan Shi, Weiyang Dai, Zishen Zhang et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
55. The structural basis of drugs targeting protein–protein interactions uncovered with the protein–ligand interaction profiler PLIP
    Bolz, Sarah Naomi, Schake, Philipp, Stitz, Celina, Schroeder, Michael · 2025 · Expert Opinion on Drug Discovery
56. PIPENN-EMB ensemble net and protein embeddings generalise protein interface prediction beyond homology
    Thomas, David P. G., Garcia Fernandez, Carlos M., Haydarlou, Reza, Feenstra, K. Anton · 2025 · Scientific Reports
57. A Dual-Specificity d -Peptide Antagonist of MDM2 and MDMX for Antitumor Immunotherapy
    Chongbing Liao, Jin Yan, William David Tolbert, Xishan Chen, Marzena Pazgier, Weiyue Lu, Changyou Zhan, Wuyuan Lu · 2025 · Journal of Medicinal Chemistry
58. Evaluating data partitioning strategies for accurate prediction of protein-ligand binding free energy changes in mutated proteins
    Liangxu Xie, Guoming Bao, Dawei Zhang, Lei Xu, Xiaojun Xu, Shan Chang · 2025 · Computational and Structural Biotechnology Journal
59. The rise of AlphaFold in drug design
    Adrian Stecuła, Rebecca Paul, Kevin Litchfield, Samuel E. Dalton, Caroline M. R. Low, Carlos R. Reis, Miles Congreve · 2025 · Progress in medicinal chemistry
60. A map of molecular drug targets and therapeutics for the US FDA-approved drugs: The impact of expedited regulatory pathways and first-in-class drug approvals on drug innovation
    Pitchai Balakumar, N. V. L. Sirisha Mulukuri, Gowraganahalli Jagadeesh · 2025 · Pharmacology & Therapeutics
61. Small Molecules Targeting the Transmembrane Domain
    Yibo Wang, Xiaohui Wang · 2025 · Journal of Medicinal Chemistry
62. Therapeutic potential of protein–protein interaction modulators in antiviral research
    Gagandeep Kaur, Komal Thapa, Parul Sood, Lata Rani, Isha Rani, Rupesh Kumar Gautam, Kavita Goyal, Haider Ali, Rakhi Mishra, Md Sadique Hussain et al. · 2025 · Bioorganic Chemistry
63. Selective Targeting of STAT6: Recent Advances and Future Perspectives
    Hua Liu, Feihai Ma, Zexu Wang, Z A Li, Jinlei Bian, Zeli Yuan, Tizhi Wu · 2026 · Medicinal Research Reviews
64. Discovering new mode‐of‐action pesticide leads inhibiting protein–protein interactions: example targeting plant O ‐acetylserine sulfhydrylase
    Rotem Shelly Ben‐Shushan, Elad Cohen, Noam Ben‐Naim, Eytan Amram, Jonathan Gressel, D Peleg, Nesly Dotan, Itai Bloch, Maayan Gal · 2024 · Pest Management Science
65. Effective drug design screening in bacterial glycolytic enzymes via targeting alternative allosteric sites
    İpek Türkmenoğlu, Gamze Kurtuluş, Cenk Sesal, Özge Kürkçüoğlu, Merve Ayyildiz, Serkan Çeliker, Fatih Ozhelvaci, Xin Du, George Y. Liu, Moshe Arditi et al. · 2024 · Archives of Biochemistry and Biophysics
66. Modulating the phosphorylation status of target proteins through bifunctional molecules
    Qindi He, Zhijie Wang, Rongrong Wang, Tao Lu, Yadong Chen, Shuai Lü · 2025 · Drug Discovery Today
67. Surface chemistry tailorable quantum dots mediated direct cytosolic delivery of proteins
    Hangyu Son, Suah Lee, Junhwa Lee, Sungjee Kim, Min‐Ho Kang, Joonhyuck Park · 2025 · Surfaces and Interfaces
68. Depletion-dependent activity-based protein profiling using SWATH/DIA-MS detects serine hydrolase lipid remodeling in lung adenocarcinoma progression
    Tatjana Sajic, Matej Vizovišek, Stephan Arni, Rodolfo Ciuffa, Martin Mehnert, Sébastien Lenglet, Walter Weder, Héctor Gallart‐Ayala, Julijana Ivanišević, Marija Buljan et al. · 2025 · Nature Communications
69. Driving Therapeutic Innovation in Neurodegenerative Disease With Hydrogen Deuterium eXchange Mass Spectrometry
    Andrea Pierangelini, Benedikt Mathias Kessler, Darragh Patrick O'Brien · 2025 · Molecular & Cellular Proteomics
70. Peptides derived from the SARS-CoV-2 receptor binding motif bind to ACE2 but do not block ACE2-mediated host cell entry or pro-inflammatory cytokine induction
    Amit Mahindra, Gonzalo S. Tejeda, Mario Rossi, Omar Janha, Imogen Herbert, Caroline Morris, Danielle C. Morgan, Wendy Beattie, Augusto C. I. Montezano, Brian D. Hudson et al. · 2021 · PLoS ONE
71. Rapid Rational Design of Cyclic Peptides Mimicking Protein–Protein Interfaces
    Brianda L. Santini, Martin Zacharias · 2022 · Methods in molecular biology
72. Synthesis of Aza-Bridged Perhydroazulene Chimeras of Tropanes and Hederacine A
    Sofiane Hocine, Edouard Duchamp, Akash Mishra, Jean‐Marie Fourquez, Stephen Hanessian · 2023 · The Journal of Organic Chemistry
73. WDR54 exerts oncogenic roles in T‐cell acute lymphoblastic leukemia
    Huan Li, Danlan Zhang, Qiuxia Fu, Shang Wang, Xin Zhang, Zhixian Lin, Zhongyuan Wang, Jiaxing Song, Zijie Su, Vivian Weiwen Xue et al. · 2023 · Cancer Science
74. Statistical Survey of Chemical and Geometric Patterns on Protein Surfaces as a Blueprint for Protein‐Mimicking Nanoparticles
    2024
75. Mechanism of β‑sitosterol in treating keloids: Network pharmacology, molecular docking and experimental verification
    Pingping Huo, Zhouna Li, Shan Jin, Sujie Wang, Yinli Luo, Lianhua Zhu, Zhehu Jin · 2025 · Molecular Medicine Reports
76. Discovery and biological evaluation of carborane-containing derivatives as TEAD auto palmitoylation inhibitors
    Chaofan Li, Yingshuang Zhang, Z Zhang, Yirong Zhang, Yuxuan Song, Linyuan Wang, Changxian Yuan, Guanxiang Hao, Nan Sun, Hongjing Li et al. · 2025 · Bioorganic & Medicinal Chemistry Letters
77. ShcD adaptor protein drives invasion of triple negative breast cancer cells by aberrant activation of EGFR signaling
    Hayley R. Lau, Hayley S. Smith, Begüm Alural, Claire Emilie Martin, Laura A. New, Manali Tilak, Sara L. Banerjee, Hannah N. Robeson, Nicolas Bisson, Anne‐Claude Gingras et al. · 2025 · Molecular Oncology
78. Targeting E3 ubiquitin ligases to sensitize cancer radiation therapy
    Zan Chen, Wei Xu · 2019 · Precision Radiation Oncology
79. Screening a Molecular Fragment Library to Modulate the PED/PEA15-Phospholipase D1 Interaction in Cellular Lysate Environments
    Biancamaria Farina, Luciano Pirone, Gianluca D’Abrosca, Maria della Valle, Luigi Russo, Carla Isernia, Marica Sassano, Annarita Del Gatto, Sonia Di Gaetano, Laura Zaccaro et al. · 2021 · ACS Chemical Biology
80. Discovery of novel druggable pockets on polyomavirus VP1 through crystallographic fragment-based screening to develop capsid assembly inhibitors
    Evgenii M. Osipov, Ali H. Munawar, Steven Beelen, D. Fearon, A. Douangamath, Conor Francis Wild, S.D. Weeks, Arthur A. Van Aerschot, F. von Delft, Sergei V. Strelkov · 2022 · RSC Chemical Biology
81. Association of two polyelectrolytes in salt solutions
    Chao Duan, Rui Wang · 2022 · Soft Matter
82. Boosting the integration of cell membrane-nanomaterial hybrids via dextran-mediated dynamic dispersion system to capture bioactive compounds in natural products
    Qi Hu, Lanlan Jia, Peishan Li, Tingting Zhang, Quzha Silang, Xiaoyu Xie, Sicen Wang · 2023 · Journal of Materials Chemistry B
83. Maleimide constrained BAD BH3 domain peptides as BCL-xL Inhibitors: A versatile approach to rapidly identify sites compatible with peptide constraining
    Peiyu Zhang, Martin Walko, Andrew John Wilson · 2023 · Bioorganic & Medicinal Chemistry Letters
84. Interaction between Yersinia pestis Ail Outer Membrane Protein and the C-Terminal Domain of Human Vitronectin
    Laurine Vasseur, Florent Barbault, Antonio Monari · 2024 · The Journal of Physical Chemistry B
85. Exploring the anticancer mechanism of cardiac glycosides using proteome integral solubility alteration approach
    Wenjie Qin, Yinhua Deng, Huan Ren, Yanling Liu, Ling Liu, Wenhui Liu, Yuxi Zhao, Chen Li, Zhiling Yang · 2024 · Cancer Medicine
86. Fragment-based methods for the discovery of inhibitors modulating lysyl-tRNA synthetase and laminin receptor interaction
    Hye Young Cho, Sung‐Hoon Kim, Young Ho Jeon · 2016 · Methods
87. A computational protocol for the discovery of lead molecules targeting DNA unique to pathogens
    Akhilesh Mishra, Pradeep Pant, Nirotpal Mrinal, Bhyravabhotla Jayaram · 2017 · Methods
88. Identifying Inhibitors of USP7-HDM2 Protein-Protein Interaction (PPI) by the in Silico Fragment-mapping Method
    Kensuke Misawa, Shin-ichiro Ozawa, Tomoki Yoshida, Izumi Nakagome, Noriyuki Yamaotsu, Shuichi Hirono · 2019 · YAKUGAKU ZASSHI
89. Should network biology be used for drug discovery?
    Francisco Martínez-Jiménez, Marc A. Martı́-Renom · 2016 · Expert Opinion on Drug Discovery
90. In vivo KRAS G12D/V degradation mediated by CANDDY using a modified proteasome inhibitor
    Satoshi Imanishi, Lijuan Huang, Shoko Itakura, Masamichi Ishizaka, Yoichi Iwasaki, Tomohiro Yamaguchi, Etsuko Miyamoto‐Sato · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
91. Introduction
    Jing Zhao, Guifang Chen · 2018 · Elsevier eBooks
92. Where to next in the evolution of in silico design of modulators targeting protein–protein interactions?
    Yibo Wang, Xiaohui Wang · 2023 · Expert Opinion on Drug Discovery
93. The WW domain of IQGAP1 binds directly to the p110α catalytic subunit of PI 3-kinase
    2023
94. A goldilocks computational protocol for inhibitor discovery targeting DNA damage responses including replication-repair functions
    Davide Moiani, John A. Tainer · 2024 · Frontiers in Molecular Biosciences
95. Rational Design of Stapled Covalent Peptide Modifiers of Oncoprotein E6 from Human Papillomavirus
    Cole Emanuelson, Yuta Naro, Olivia Shade, Melinda Liu, Sagar D. Khare, Alexander Deiters · 2025 · ACS Chemical Biology
96. Revitalizing natural products for sustainable drug Discovery: Innovations bridging food bioscience and green therapeutic development
    Ramachandran Chelliah, Selvakumar Vijayalakshmi, Murugan Karuvelan, Kaliyan Barathikannan, Sulav Ghimeray, Deog‐Hwan Oh · 2025 · Sustainable Chemistry and Pharmacy
97. Fulcrum Occupancy–Leverage Perturbation Strategy Enables Rapid Discovery of Potent CDK2–Cyclin A2 Interaction Inhibitors
    Ge Sun, Shuaishuai Chi, Jiacheng Li, Pan Xu, Tingting Lin, Chao Chen, Liping Liu, Yu-Lin Yang, Ruyu Yan, Hongbo Han et al. · 2025 · Angewandte Chemie International Edition
98. Hot-Spot-Guided Generative Deep Learning for Drug-Like PPI Inhibitor Design
    Heqi Sun, Jiayi Li, Yufang Zhang, Shenggeng Lin, Junwei Chen, Hong Tan, Ruixuan Wang, Xueying Mao, Jianwei Zhao, Rongpei Li et al. · 2025 · Interdisciplinary Sciences Computational Life Sciences
99. Identification and Characterization of ERK2 Dimerization Inhibitors by Integrated In Silico and In Vitro Screening
    Carmen Ortiz-González, Berta Casar, Rafael Gozalbes, Eva Serrano‐Candelas, Piero Crespo, Laureano E. Carpio · 2025 · International Journal of Molecular Sciences
100. Influence of Amino Acid Mutations and Small Molecules on Targeted Inhibition of Proteins Involved in Cancer
     Vishnupriya Kanakaveti, P. Anoosha, Ramasamy Sakthivel, Suresh Kumar Rayala, M. Michael Gromiha · 2019 · Current Topics in Medicinal Chemistry